Phage display, a 60-year-old technology for antibody screening, expresses antibodies on phage surface proteins such as pIII and pVIII. pVIII is most widely used with about 3,000 copies to boost signals. It offers a large library capacity of 1E10–1E11. Using E. coli expression, it features simple operation and short cycles. NabLife’s NabLib® platform provides phage display-based antibody discovery and engineering for drug development.
Technical principle：
|
Phage Display Technical principle |
Dual-function plasmid system |
 |
 |
Service process：
Comparison of Antibody Display Techniques：
Service Features：
|
|
|
|
|
 |
 |
 |
 |
|
Efficient antibody screening
Obtain the antibody sequence within 4 weeks |
One step at a time
Thermal stability test |
Switch freely
Phage display - Antibody secretion |
Extensive storage capacity
Meet the requirements of antibody screening |
Representative cases :